CCL5-armed Oncolytic Virus Augments CCR5-engineered NK Cell Infiltration and Antitumor Efficiency

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1136/jitc-2019-000131
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Chemovirotherapy for Head and Neck Squamous Cell Carcinoma With EGFR-targeted and CD/UPRT-armed Oncolytic Measles Virus

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2011English

Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-Expressing Oncolytic Virus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies

Frontiers in Immunology
AllergyImmunology
2016English

Active Secretion of CXCL10 and CCL5 From Colorectal Cancer Microenvironments Associates With GranzymeB+ CD8+ T-Cell Infiltration

Oncotarget
Oncology
2015English

Soluble Fc-Disabled Herpes Virus Entry Mediator Augments Activation and Cytotoxicity of NK Cells by Promoting Cross-Talk Between NK Cells and Monocytes

Journal of Immunology
AllergyImmunology
2019English

Cytokine-Induced Killer Cell Delivery Enhances the Antitumor Activity of Oncolytic Reovirus

PLoS ONE
Multidisciplinary
2017English

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1bb Signaling Induced by an Armed Oncolytic Virus

Clinical Cancer Research
Cancer ResearchOncology
2017English

61PArming Oncolytic Adenovirus With FAP-targeting Bispecific T-Cell Engager to Improve Antitumor Efficacy

Annals of Oncology
MedicineOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy